| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0078 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |